Lievens Y - Search Results

1

Radiation Oncology. Optimal Health for All, Together. ESTRO vision, 2030.

Lievens Y, Ricardi U, Poortmans P, Verellen D, Gasparotto C, Verfaillie C, Cortese AJ. Lievens Y, et al. Radiother Oncol. 2019 Jul;136:86-97. doi: 10.1016/j.radonc.2019.03.031. Epub 2019 Apr 11. Radiother Oncol. 2019. PMID: 31015134

2

The time course of development of late side effects after irradiation of the prostate with multiple fractions per day.

Lievens Y, Vanuytsel L, Rijnders A, Van Poppel H, van der Schueren E. Lievens Y, et al. Radiother Oncol. 1996 Aug;40(2):147-52. doi: 10.1016/0167-8140(96)01774-4. Radiother Oncol. 1996. PMID: 8884968

3

Palliative radiotherapy practice within Western European countries: impact of the radiotherapy financing system?

Lievens Y, Van den Bogaert W, Rijnders A, Kutcher G, Kesteloot K. Lievens Y, et al. Radiother Oncol. 2000 Sep;56(3):289-95. doi: 10.1016/s0167-8140(00)00214-0. Radiother Oncol. 2000. PMID: 10974377

4

Differences in palliative radiotherapy for bone metastases within Western European countries.

Lievens Y, Kesteloot K, Rijnders A, Kutcher G, Van den Bogaert W. Lievens Y, et al. Radiother Oncol. 2000 Sep;56(3):297-303. doi: 10.1016/s0167-8140(00)00215-2. Radiother Oncol. 2000. PMID: 10974378

5

A glance on quality assurance in EORTC study 22922 evaluating techniques for internal mammary and medial supraclavicular lymph node chain irradiation in breast cancer.

Lievens Y, Poortmans P, Van den Bogaert W. Lievens Y, et al. Radiother Oncol. 2001 Sep;60(3):257-65. doi: 10.1016/s0167-8140(01)00351-6. Radiother Oncol. 2001. PMID: 11514005

6

CHART in lung cancer: economic evaluation and incentives for implementation.

Lievens Y, Kesteloot K, Van den Bogaert W. Lievens Y, et al. Radiother Oncol. 2005 May;75(2):171-8. doi: 10.1016/j.radonc.2005.03.011. Radiother Oncol. 2005. PMID: 15878631

7

Overview of national guidelines for infrastructure and staffing of radiotherapy. ESTRO-QUARTS: work package 1.

Slotman BJ, Cottier B, Bentzen SM, Heeren G, Lievens Y, van den Bogaert W. Slotman BJ, et al. Among authors: lievens y. Radiother Oncol. 2005 Jun;75(3):349-54. doi: 10.1016/j.radonc.2004.12.005. Epub 2004 Dec 23. Radiother Oncol. 2005. PMID: 15893832

8

Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines.

Girinsky T, van der Maazen R, Specht L, Aleman B, Poortmans P, Lievens Y, Meijnders P, Ghalibafian M, Meerwaldt J, Noordijk E. Girinsky T, et al. Among authors: lievens y. Radiother Oncol. 2006 Jun;79(3):270-7. doi: 10.1016/j.radonc.2006.05.015. Epub 2006 Jun 22. Radiother Oncol. 2006. PMID: 16797755

9

The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines.

Girinsky T, Specht L, Ghalibafian M, Edeline V, Bonniaud G, Van Der Maazen R, Aleman B, Paumier A, Meijnders P, Lievens Y, Noordijk E, Poortmans P; EORTC-GELA Lymphoma Group. Girinsky T, et al. Among authors: lievens y. Radiother Oncol. 2008 Aug;88(2):202-10. doi: 10.1016/j.radonc.2008.05.012. Epub 2008 Jun 12. Radiother Oncol. 2008. PMID: 18555548

10

A systematic methodology review of phase I radiation dose escalation trials.

Pijls-Johannesma M, van Mastrigt G, Hahn SM, De Ruysscher D, Baumert BG, Lammering G, Buijsen J, Bentzen SM, Lievens Y, Kramar A, Lambin P. Pijls-Johannesma M, et al. Among authors: lievens y. Radiother Oncol. 2010 May;95(2):135-41. doi: 10.1016/j.radonc.2010.02.009. Epub 2010 Mar 24. Radiother Oncol. 2010. PMID: 20338652

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

206 results

Search Page